Home » Topics » Regulatory

Regulatory
RSS

Third indication studied for SGN-30 in new phase II trial

Sep. 29, 2004

Expanded indication for Eloxatin for early stage colon cancer treatment

Sep. 21, 2004

Nexium completes European mutual recognition procedure for new indications

Sep. 20, 2004

Vioxx approved for once-daily treatment of juvenile rheumatoid arthritis

Sep. 9, 2004

Proscar approved for new indication in Canada

Sep. 7, 2004

Clarinex syrup approved for use in children with allergies, hives

Sep. 3, 2004

sNDA submission for Merrem for complicated skin and skin structure infections

Aug. 5, 2004

Aldara receives approval for superficial basal cell carcinoma

July 20, 2004

Lyrica approved in E.U.

July 12, 2004

Eisai launches Apnission in Japan

July 6, 2004